Abstract
Objectives
To assess the association between erectile dysfunction and subjective well-being among primary care patients with type 2 diabetes mellitus.
Methods
This cross-sectional study included 340 men with type 2 diabetes treated in primary health care settings in the Ismailia governorate between April 2021 and April 2022. A multistage random cluster sampling technique was used. Sociodemographic data, disease characteristics, lifestyle, surgical and sexual history, and the Arabic translations of the abridged 5-item version of the International Index of Erectile Function (IIEF-5) Questionnaire, and the 5-item World Health Organization Well-Being Index (WHO-5) were gathered.
Results
Erectile dysfunction was identified in 72.94% of diabetic patients, with 55% mild or mild-to-moderate (ED I), and 17.9% moderate or severe (ED II). Twenty percent had Poor subjective well-being, with a mean WHO-5 index of 63.4 (± 15.4). Binary logistic regression analysis showed that education, diabetes duration, insufficient income, dyslipidemia, benign prostate hyperplasia, and IIEF-5 score were significantly associated with poor subjective well-being. Increasing IIEF-5 score was significantly associated with a 22% decrease in the odds of poor subjective well-being (OR: 0.78; 95% CI 0.66–0.93). Multinomial regression analysis showed that increasing score of the WHO-5 well-being index was associated with a 11% and 14% reduction in the odds of ED I and II, respectively (OR: 0.89 (95% CI 0.86–0.93), and 0.86 (95% CI 0.81–0.92), respectively).
Conclusion
Erectile dysfunction and subjective well-being were interrelated. Early detection of erectile dysfunction is essential for improving the positive mental health of men with type 2 diabetes in primary care.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
International Diabetes Federation. IDF Diabetes Atlas—10th Edition. Brussels, Belgium: International Diabetes Federation; 2021. http://www.diabetesatlas.org/. Accessed 6 May 2022.
Altun I, Demirhan Y, Erkek Y, Peker A, Çetinarslan B. Subjective well-being of persons with type 2 diabetes mellitus. Popul Health Manag. 2014;17(4):253–4. https://doi.org/10.1089/pop.2014.0013.
Holmes-Truscott E, Browne JI, Pouwer F, Speight J, Cummins RA. Subjective wellbeing among adults with diabetes: results from diabetes MILES—Australia. J Happiness Stud. 2016;17:1205–17. https://doi.org/10.1007/s10902-015-9638-4.
Ruggeri K, Garcia-Garzon E, Maguire Á, Matz S, Huppert FA. Well-being is more than happiness and life satisfaction: a multidimensional analysis of 21 countries. Health Qual Life Outcomes. 2020;18(1):192. https://doi.org/10.1186/s12955-020-01423-y.
Zanuso S, Balducci S, Jimenez A. Physical activity, a key factor to quality of life in type 2 diabetic patients. Diabetes Metab Res Rev. 2009;25(Suppl 1):S24–8. https://doi.org/10.1002/dmrr.984.
Diener E, Chan MY. Happy people live longer: subjective well-being contributes to health and longevity. Appl Psychol Health Well Being. 2011;3(1):1–43. https://doi.org/10.1111/j.1758-0854.2010.01045.x.
Papanas N, Tsapas A, Papatheodorou K, Papazoglou D, Bekiari E, Sariganni M, et al. Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2010;118(6):364–7. https://doi.org/10.1055/s-0029-1243623.
Ramkisson S, Pillay BJ, Sartorius B. Anxiety, depression and psychological well-being in a cohort of South African adults with type 2 diabetes mellitus. S Afr J Psychiatr. 2016;22(1):935. https://doi.org/10.4102/sajpsychiatry.v22i1.935.
Mirahmadizadeh A, Mahizadeh H, Seif M, Sharifi MH. Factors related to psychological well-being amongst patients with type 2 diabetes. Diabetes Res Clin Pract. 2021;178: 108982. https://doi.org/10.1016/j.diabres.2021.108982.
Speight J, Hendrieckx C, Pouwer F, Skinner TC, Snoek FJ. Back to the future: 25 years of “Guidelines for encouraging psychological well-being” among people affected by diabetes. Diabet Med. 2020;37(8):1225–9. https://doi.org/10.1111/dme.14165.
Kizilay F, Gali HE, Serefoglu EC. Diabetes and sexuality. Sex Med Rev. 2017;5(1):45–51. https://doi.org/10.1016/j.sxmr.2016.07.002.
McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13(2):135–43. https://doi.org/10.1016/j.jsxm.2015.12.019.
Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185–92. https://doi.org/10.1111/dme.13403.
Salama N. Sexual dysfunctions as self-reported by diabetic-type-2 men: an andrology clinic-based study in Alexandria. Egypt Am J Med Biol Res. 2013;1(3):50–7. https://doi.org/10.12691/ajmbr-1-3-1.
Ghanem YM, Zahran ARM, Younan DN, Zeitoun MH, El Feky AY. Prevalence of erectile dysfunction among Egyptian male patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2021;15(3):949–53. https://doi.org/10.1016/j.dsx.2021.04.019.
el-Rufaie OE, Bener A, Abuzeid MS, Ali TA. Sexual dysfunction among type II diabetic men: a controlled study. J Psychosom Res. 1997;43(6):605–12. https://doi.org/10.1016/s0022-3999(97)00183-9.
Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int. 2007;99(1):130–4. https://doi.org/10.1111/j.1464-410X.2006.06550.x.
El-Sakka AI. Erectile dysfunction in Arab countries. Part I: prevalence and correlates. Arab J Urol. 2012;10(2):97–103. https://doi.org/10.1016/j.aju.2012.01.004.
AlMogbel TA. Erectile dysfunction and other sexual activity dysfunctions among saudi type 2 diabetic patients. Int J Health Sci (Qassim). 2014;8(4):347–59.
Lo WH, Fu SN, Wong CK, Chen ES. Prevalence, correlates, attitude and treatment seeking of erectile dysfunction among type 2 diabetic Chinese men attending primary care outpatient clinics. Asian J Androl. 2014;16(5):755–60. https://doi.org/10.4103/1008-682X.127823.
Russo GI, Cimino S, Fragalà E, Privitera S, La Vignera S, Condorelli R, et al. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study. J Sex Med. 2014;11(8):2074–82. https://doi.org/10.1111/jsm.12587.
Castela Â, Costa C. Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nat Rev Urol. 2016;13(5):266–74. https://doi.org/10.1038/nrurol.2016.23.
Santi D, Granata AR, Guidi A, Pignatti E, Trenti T, Roli L, et al. Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial. Eur J Endocrinol. 2016;174(4):513–22. https://doi.org/10.1530/EJE-15-1100.
Gianatti EJ, Grossmann M. Testosterone deficiency in men with type 2 diabetes: pathophysiology and treatment. Diabet Med. 2020;37(2):174–86. https://doi.org/10.1111/dme.13977.
Maalmi H, Herder C, Bönhof GJ, Strassburger K, Zaharia OP, Rathmann W, et al. Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetologia. 2022;65(3):552–62. https://doi.org/10.1007/s00125-021-05607-z.
Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38(2): e3494. https://doi.org/10.1002/dmrr.3494.
Ma RC, So WY, Yang X, Yu LW, Kong AP, Ko GT, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol. 2008;51(21):2045–50. https://doi.org/10.1016/j.jacc.2008.02.051.
Batty GD, Li Q, Czernichow S, Neal B, Zoungas S, Huxley R, ADVANCE Collaborative Group, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2010;56(23):1908–13. https://doi.org/10.1016/j.jacc.2010.04.067.
García-Malpartida K, Mármol R, Jover A, Gómez-Martínez MJ, Solá-Izquierdo E, Victor VM, et al. Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications. J Sex Med. 2011;8(9):2606–16. https://doi.org/10.1111/j.1743-6109.2011.02365.x.
Chen S, Peng D, Xu X, Gao J, Dai F, Zuo C, et al. Assessment of erectile dysfunction and associated psychological distress in Chinese men with type 2 diabetes mellitus. Int J Impot Res. 2017;29(5):210–4. https://doi.org/10.1038/ijir.2017.25.
Bąk E, Marcisz C, Krzemińska S, Dobrzyn-Matusiak D, Foltyn A, Drosdzol-Cop A. Relationships of sexual dysfunction with depression and acceptance of illness in women and men with type 2 diabetes mellitus. Int J Environ Res Public Health. 2017;14(9):1073. https://doi.org/10.3390/ijerph14091073.
De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care. 2002;25(2):284–91. https://doi.org/10.2337/diacare.25.2.284.
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60. https://doi.org/10.3758/BRM.41.4.1149.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–26. https://doi.org/10.1038/sj.ijir.3900472.
Shamloul R, Ghanem H, Abou-zeid A. Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res. 2004;16(5):452–5. https://doi.org/10.1038/sj.ijir.3901248.
Hajos TR, Pouwer F, Skovlund SE, Den Oudsten BL, Geelhoed-Duijvestijn PH, Tack CJ, et al. Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with type 1 or type 2 diabetes mellitus. Diabet Med. 2013;30(2):e63–9. https://doi.org/10.1111/dme.12040.
Sibai AM, Chaaya M, Tohme RA, Mahfoud Z, Al-Amin H. Validation of the Arabic version of the 5-item WHO Well Being Index in elderly population. Int J Geriatr Psychiatry. 2009;24(1):106–7. https://doi.org/10.1002/gps.2079.
American Diabetes Association. Standards of medical care in diabetes—2020 abridged for primary care providers. Clin Diabetes. 2020;38(1):10–38. https://doi.org/10.2337/cd20-as01.
Zeleke M, Hailu D, Daka D. Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia. BMC Endocr Disord. 2021;21(1):139. https://doi.org/10.1186/s12902-021-00807-5.
Ugwu T, Ezeani I, Onung S, Kolawole B, Ikem R. Predictors of erectile dysfunction in men with type 2 diabetes mellitus referred to a tertiary healthcare centre. Adv Endocrinol. 2016;2016(8):1–8. https://doi.org/10.1155/2016/9753154.
Mulhall JP, Giraldi A, Hackett G, Hellstrom WJG, Jannini EA, Rubio-Aurioles E, et al. The 2018 revision to the process of care model for evaluation of erectile dysfunction. J Sex Med. 2018;15(9):1280–92. https://doi.org/10.1016/j.jsxm.2018.06.005.
Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Ranasinghe P, Levy JC. Erectile dysfunction is a strong predictor of poor quality of life in men with type 2 diabetes mellitus. Diabet Med. 2014;31(6):699–706. https://doi.org/10.1111/dme.12412.
Li C, Xia Y, Zhang Y. Relationship between subjective well-being and depressive disorders: novel findings of cohort variations and demographic heterogeneities. Front Psychol. 2023;13:1022643. https://doi.org/10.3389/fpsyg.2022.1022643.
De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, et al. Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes. J Urol. 2007;177(1):252–7. https://doi.org/10.1016/j.juro.2006.08.102.
Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204–9. https://doi.org/10.1038/ijir.2010.1.
Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, et al. Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo Study. Int J Impot Res. 2017;29(2):57–60. https://doi.org/10.1038/ijir.2016.45.
Vasconcelos P, Paúl C, Serruya SJ, Ponce de León RG, Nobre P. A systematic review of sexual health and subjective well-being in older age groups. Rev Panam Salud Publica. 2022;46:e179. https://doi.org/10.26633/RPSP.2022.179.
Chuang YC, Chung MS, Wang PW, Lee WC, Chen CD, Chang HW, et al. Albuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2012;9(4):1055–64.
Sayed Ahmed HA, Fouad AM, Elotla SF, Joudeh AI, Mostafa M, Shah A, et al. Prevalence and associated factors of diabetes distress, depression and anxiety among primary care patients with type 2 diabetes during the COVID-19 pandemic in Egypt: a cross-sectional study. Front Psychiatry. 2022;13: 937973. https://doi.org/10.3389/fpsyt.2022.937973.
McLeish AC, Smith T, Riggs DW, Hart JL, Walker KL, Keith RJ, et al. Community-based evaluation of the associations between well-being and cardiovascular disease risk. J Am Heart Assoc. 2022;11(22): e027095. https://doi.org/10.1161/JAHA.122.027095.
Kim MT, Kim KB, Ko J, Jang Y, Levine D, Lee HB. Role of depression in diabetes management in an ethnic minority population: a case of Korean Americans with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1): e000337. https://doi.org/10.1136/bmjdrc-2016-000337.
Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Fernando DJ, Levy JC. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J Sex Med. 2008;5(9):2125–34.
Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2015;12(12):2291–300.
Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male. 2019;22(1):12–9.
Chung RY, Leung JC, Chan DC, Woo J, Wong CK, Wong SY. Lower urinary tract symptoms (LUTS) as a risk factor for depressive symptoms in elderly men: results from a large prospective study in Southern Chinese men. PLoS ONE. 2013;8(9): e76017. https://doi.org/10.1371/journal.pone.0076017.
Dunphy C, Laor L, Te A, Kaplan S, Chughtai B. Relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Rev Urol. 2015;17(2):51–7. https://doi.org/10.3909/riu0658.
Jeong WS, Choi HY, Nam JW, Kim SA, Choi BY, Moon HS, et al. Men with severe lower urinary tract symptoms are at increased risk of depression. Int Neurourol J. 2015;19(4):286–92. https://doi.org/10.5213/inj.2015.19.4.286.
Acknowledgements
Deepest appreciation for primary care patients with T2DM who participated in this study.
Funding
This research did not receive external funding.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. EMA collected the data. AMF analyzed these data. The first draft of the manuscript was written by HASA, TMA, and AMF. HASA, and EMA contributed equally to this work and shared the first authorship. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The study was approved by the Research Ethics Committee at the Faculty of Medicine, Suez Canal University, Ismailia, Egypt (Reference number 4099/2020, dated 17/2/2020). Informed consent was obtained from the participants before enrollment in the study.
Human rights statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and later versions.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sayed Ahmed, H.A., Abdallah, E.M., Mohamed, M.A. et al. Association between erectile dysfunction and subjective well-being in primary care patients with type 2 diabetes. Diabetol Int (2024). https://doi.org/10.1007/s13340-024-00699-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13340-024-00699-5